Global Rotavirus Infection Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: G9E2BD51ED99EN
QYResearch

Abstracts

This report focuses on the global Rotavirus Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rotavirus Infection Therapeutics development in North America, Europe and Asia-Pacific.

The key players covered in this study

• GlaxoSmithKline
• Bharat Biotech
• Curevac
• Ology Bioservices
• BioKangtai

Market segment by Type, the product can be split into

• Oral Drug
• Injiectable Drug

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Rotavirus Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Rotavirus Infection Therapeutics development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rotavirus Infection Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Drug
  1.4.3 Injiectable Drug
1.5 Market by Application
  1.5.1 Global Rotavirus Infection Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Rotavirus Infection Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Rotavirus Infection Therapeutics Industry
    1.6.1.1 Rotavirus Infection Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Rotavirus Infection Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Rotavirus Infection Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Rotavirus Infection Therapeutics Market Perspective (2015-2026)
2.2 Rotavirus Infection Therapeutics Growth Trends by Regions
  2.2.1 Rotavirus Infection Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Rotavirus Infection Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Rotavirus Infection Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Rotavirus Infection Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Rotavirus Infection Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Rotavirus Infection Therapeutics Players by Market Size
  3.1.1 Global Top Rotavirus Infection Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rotavirus Infection Therapeutics Market Concentration Ratio
  3.2.1 Global Rotavirus Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Rotavirus Infection Therapeutics Revenue in 2019
3.3 Rotavirus Infection Therapeutics Key Players Head office and Area Served
3.4 Key Players Rotavirus Infection Therapeutics Product Solution and Service
3.5 Date of Enter into Rotavirus Infection Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Rotavirus Infection Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2021-2026)

5 ROTAVIRUS INFECTION THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Rotavirus Infection Therapeutics Market Size by Application (2015-2020)
5.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Rotavirus Infection Therapeutics Market Size (2015-2020)
6.2 Rotavirus Infection Therapeutics Key Players in North America (2019-2020)
6.3 North America Rotavirus Infection Therapeutics Market Size by Type (2015-2020)
6.4 North America Rotavirus Infection Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Rotavirus Infection Therapeutics Market Size (2015-2020)
7.2 Rotavirus Infection Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Rotavirus Infection Therapeutics Market Size by Type (2015-2020)
7.4 Europe Rotavirus Infection Therapeutics Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Rotavirus Infection Therapeutics Market Size (2015-2020)
8.2 Rotavirus Infection Therapeutics Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Type (2015-2020)
8.4 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 GlaxoSmithKline
  9.1.1 GlaxoSmithKline Company Details
  9.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Introduction
  9.1.4 GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2015-2020))
  9.1.5 GlaxoSmithKline Recent Development
9.2 Bharat Biotech
  9.2.1 Bharat Biotech Company Details
  9.2.2 Bharat Biotech Business Overview and Its Total Revenue
  9.2.3 Bharat Biotech Rotavirus Infection Therapeutics Introduction
  9.2.4 Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2015-2020)
  9.2.5 Bharat Biotech Recent Development
9.3 Curevac
  9.3.1 Curevac Company Details
  9.3.2 Curevac Business Overview and Its Total Revenue
  9.3.3 Curevac Rotavirus Infection Therapeutics Introduction
  9.3.4 Curevac Revenue in Rotavirus Infection Therapeutics Business (2015-2020)
  9.3.5 Curevac Recent Development
9.4 Ology Bioservices
  9.4.1 Ology Bioservices Company Details
  9.4.2 Ology Bioservices Business Overview and Its Total Revenue
  9.4.3 Ology Bioservices Rotavirus Infection Therapeutics Introduction
  9.4.4 Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2015-2020)
  9.4.5 Ology Bioservices Recent Development
9.5 BioKangtai
  9.5.1 BioKangtai Company Details
  9.5.2 BioKangtai Business Overview and Its Total Revenue
  9.5.3 BioKangtai Rotavirus Infection Therapeutics Introduction
  9.5.4 BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2015-2020)
  9.5.5 BioKangtai Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Rotavirus Infection Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue
Table 3. Ranking of Global Top Rotavirus Infection Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drug
Table 6. Key Players of Injiectable Drug
Table 7. COVID-19 Impact Global Market: (Four Rotavirus Infection Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Rotavirus Infection Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Rotavirus Infection Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Rotavirus Infection Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Rotavirus Infection Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Rotavirus Infection Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Rotavirus Infection Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Rotavirus Infection Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Rotavirus Infection Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Rotavirus Infection Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Rotavirus Infection Therapeutics Players
Table 23. Global Rotavirus Infection Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Rotavirus Infection Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infection Therapeutics as of 2019)
Table 26. Global Rotavirus Infection Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Rotavirus Infection Therapeutics Product Solution and Service
Table 29. Date of Enter into Rotavirus Infection Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Rotavirus Infection Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Rotavirus Infection Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Rotavirus Infection Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Rotavirus Infection Therapeutics Market Share (2019-2020)
Table 39. North America Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Rotavirus Infection Therapeutics Market Share by Type (2015-2020)
Table 41. North America Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Rotavirus Infection Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Rotavirus Infection Therapeutics Market Share (2019-2020)
Table 45. Europe Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Rotavirus Infection Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Rotavirus Infection Therapeutics Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Rotavirus Infection Therapeutics Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Rotavirus Infection Therapeutics Market Share (2019-2020)
Table 51. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Type (2015-2020)
Table 53. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Application (2015-2020)
Table 55. GlaxoSmithKline Company Details
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Product
Table 58. GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$)
Table 59. GlaxoSmithKline Recent Development
Table 60. Bharat Biotech Company Details
Table 61. Bharat Biotech Business Overview
Table 62. Bharat Biotech Product
Table 63. Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$)
Table 64. Bharat Biotech Recent Development
Table 65. Curevac Company Details
Table 66. Curevac Business Overview
Table 67. Curevac Product
Table 68. Curevac Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$)
Table 69. Curevac Recent Development
Table 70. Ology Bioservices Company Details
Table 71. Ology Bioservices Business Overview
Table 72. Ology Bioservices Product
Table 73. Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$)
Table 74. Ology Bioservices Recent Development
Table 75. BioKangtai Company Details
Table 76. BioKangtai Business Overview
Table 77. BioKangtai Product
Table 78. BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2015-2020) (Million US$)
Table 79. BioKangtai Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Rotavirus Infection Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Drug Features
Figure 3. Injiectable Drug Features
Figure 4. Global Rotavirus Infection Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Rotavirus Infection Therapeutics Report Years Considered
Figure 9. Global Rotavirus Infection Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rotavirus Infection Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Rotavirus Infection Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rotavirus Infection Therapeutics Market Share by Players in 2019
Figure 14. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infection Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2019
Figure 16. North America Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Rotavirus Infection Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. GlaxoSmithKline Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020)
Figure 21. Bharat Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Bharat Biotech Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020)
Figure 23. Curevac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Curevac Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020)
Figure 25. Ology Bioservices Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Ology Bioservices Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020)
Figure 27. BioKangtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioKangtai Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2015-2020)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed